{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T22:54:02Z","timestamp":1774479242084,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:00:00Z","timestamp":1791590400000},"content-version":"am","delay-in-days":313,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015615","name":"National Institute on Drug Abuse Clinical Trials Network","doi-asserted-by":"publisher","award":["3UG1DA040314"],"award-info":[{"award-number":["3UG1DA040314"]}],"id":[{"id":"10.13039\/100015615","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015615","name":"National Institute on Drug Abuse Clinical Trials Network","doi-asserted-by":"publisher","award":["UG1 DA013714"],"award-info":[{"award-number":["UG1 DA013714"]}],"id":[{"id":"10.13039\/100015615","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015615","name":"National Institute on Drug Abuse Clinical Trials Network","doi-asserted-by":"publisher","award":["UG1DA015815"],"award-info":[{"award-number":["UG1DA015815"]}],"id":[{"id":"10.13039\/100015615","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajpm-online.net","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Medicine"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.amepre.2025.108085","type":"journal-article","created":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T22:22:46Z","timestamp":1757197366000},"page":"108085","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Risks for Adverse Events by Sex and Age After Prescription Opioid Dose Reduction"],"prefix":"10.1016","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9720-424X","authenticated-orcid":false,"given":"Verena E.","family":"Metz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3256-579X","authenticated-orcid":false,"given":"Vanessa A.","family":"Palzes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8862-8078","authenticated-orcid":false,"given":"Ingrid A.","family":"Binswanger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Altschuler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5915-371X","authenticated-orcid":false,"given":"Melissa N.","family":"Poulsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4291-4516","authenticated-orcid":false,"given":"Brian K.","family":"Ahmedani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan E.","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin E.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rulin C.","family":"Hechter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Horberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffani R.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kari A.","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea L.","family":"Rubinstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia I.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amepre.2025.108085_bib0001","unstructured":"Opioid Dispensing Rate Maps, Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/overdose-prevention\/data-research\/facts-stats\/opioid-dispensing-rate-maps.html?CDC_AAref_Val=https:\/\/www.cdc.gov\/drugoverdose\/rxrate-maps\/opioid.html. Updated August 20, 2025. Accessed July 1, 2025."},{"issue":"3","key":"10.1016\/j.amepre.2025.108085_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC clinical practice guideline for prescribing opioids for pain - United States, 2022","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR Recomm Rep"},{"issue":"11","key":"10.1016\/j.amepre.2025.108085_bib0003","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.16271","article-title":"Trends and rapidity of dose tapering among patients prescribed long-term opioid therapy, 2008\u20132017","volume":"2","author":"Fenton","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.amepre.2025.108085_bib0004","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/jama.2021.11013","article-title":"Association of dose tapering with overdose or mental health crisis among patients prescribed long-term opioids","volume":"326","author":"Agnoli","year":"2021","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.amepre.2025.108085_bib0005","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.16726","article-title":"Long-term risk of overdose or mental health crisis after opioid dose tapering","volume":"5","author":"Fenton","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"8","key":"10.1016\/j.amepre.2025.108085_bib0006","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.26523","article-title":"Comparative effectiveness of opioid tapering or abrupt discontinuation vs no dosage change for opioid overdose or suicide for patients receiving stable long-term opioid therapy","volume":"5","author":"Larochelle","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.amepre.2025.108085_bib0007","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1007\/s11606-023-08459-y","article-title":"Prescription opioid dose reductions and potential adverse events: a multi-site observational cohort study in diverse U.S. health systems","volume":"39","author":"Metz","year":"2024","journal-title":"J Gen Intern Med"},{"issue":"1","key":"10.1016\/j.amepre.2025.108085_bib0008","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/bja\/aet127","article-title":"Sex differences in pain: a brief review of clinical and experimental findings","volume":"111","author":"Bartley","year":"2013","journal-title":"Br J Anaesth"},{"issue":"10","key":"10.1016\/j.amepre.2025.108085_bib0009","doi-asserted-by":"crossref","first-page":"pgae453","DOI":"10.1093\/pnasnexus\/pgae453","article-title":"Self-regulated analgesia in males but not females is mediated by endogenous opioids","volume":"3","author":"Dean","year":"2024","journal-title":"PNAS Nexus"},{"issue":"5","key":"10.1016\/j.amepre.2025.108085_bib0010","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/09540261.2018.1514295","article-title":"Systematic review of sex-based differences in opioid-based effects","volume":"30","author":"Huhn","year":"2018","journal-title":"Int Rev Psychiatry"},{"issue":"1","key":"10.1016\/j.amepre.2025.108085_bib0011","doi-asserted-by":"crossref","first-page":"8460","DOI":"10.1038\/s41598-023-35673-9","article-title":"Sex differences in VTA GABA transmission and plasticity during opioid withdrawal","volume":"13","author":"Kalamarides","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.amepre.2025.108085_bib0012","series-title":"The pain gap: why women\u2019s pain is undertreated","author":"Latifi","year":"2021"},{"issue":"January","key":"10.1016\/j.amepre.2025.108085_bib0013","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jcbs.2022.01.002","article-title":"Gender differences in multidisciplinary pain rehabilitation: the mediating role of pain acceptance","volume":"23","author":"Pester","year":"2022","journal-title":"J Contextual Behav Sci"},{"issue":"11","key":"10.1016\/j.amepre.2025.108085_bib0014","doi-asserted-by":"crossref","first-page":"298","DOI":"10.15585\/mmwr.mm6911a5","article-title":"Variation in adult outpatient opioid prescription dispensing by age and sex - United States, 2008\u20132018","volume":"69","author":"Schieber","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.amepre.2025.108085_bib0015","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/YCO.0000000000000337","article-title":"Sex differences in prescription opioid use","volume":"30","author":"Serdarevic","year":"2017","journal-title":"Curr Opin Psychiatry"},{"issue":"12","key":"10.1016\/j.amepre.2025.108085_bib0016","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1111\/bcp.16218","article-title":"Sex differences in comorbid pain and opioid use disorder: a scoping review","volume":"90","author":"DeVito","year":"2024","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.amepre.2025.108085_bib0017","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/ajad.12921","article-title":"Review: sex-based differences in treatment outcomes for persons with opioid use disorder","volume":"28","author":"Huhn","year":"2019","journal-title":"Am J Addict"},{"issue":"1","key":"10.1016\/j.amepre.2025.108085_bib0018","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/ADM.0000000000000086","article-title":"Sex differences among opioid-abusing patients with chronic pain in a clinical trial","volume":"9","author":"Manubay","year":"2015","journal-title":"J Addict Med"},{"issue":"5","key":"10.1016\/j.amepre.2025.108085_bib0019","article-title":"Sex differences in the response to opioids for pain relief: a systematic review and meta-analysis","volume":"148","author":"Pisanu","year":"2019","journal-title":"Pharmacol Res"},{"issue":"8","key":"10.1016\/j.amepre.2025.108085_bib0020","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jama.2014.9405","article-title":"Management of persistent pain in the older patient: a clinical review","volume":"312","author":"Makris","year":"2014","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.amepre.2025.108085_bib0021","doi-asserted-by":"crossref","first-page":"ooac030","DOI":"10.1093\/jamiaopen\/ooac030","article-title":"Development and implementation of a prescription opioid registry across diverse health systems","volume":"5","author":"Ray","year":"2022","journal-title":"JAMIA Open"},{"issue":"4","key":"10.1016\/j.amepre.2025.108085_bib0022","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"issue":"10129","key":"10.1016\/j.amepre.2025.108085_bib0023","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jsat.2016.06.008","article-title":"Reasons for benzodiazepine use among persons seeking opioid detoxification","volume":"68","author":"Stein","year":"2016","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"10.1016\/j.amepre.2025.108085_bib0024","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.jpain.2023.11.002","article-title":"Impact of opioid dose reductions on patient-reported mental health and suicide-related behavior and relationship to patient choice in tapering decisions","volume":"25","author":"Yarborough","year":"2024","journal-title":"J Pain"},{"issue":"6","key":"10.1016\/j.amepre.2025.108085_bib0025","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.amepre.2025.108085_bib0026","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.mayocp.2013.12.008","article-title":"Epidemiology of emergency department visits for opioid overdose: a population-based study","volume":"89","author":"Hasegawa","year":"2014","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.amepre.2025.108085_bib0027","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ajem.2016.11.054","article-title":"Benzodiazepine-opioid co-prescribing in a national probability sample of ED encounters","volume":"35","author":"Kim","year":"2017","journal-title":"Am J Emerg Med"},{"issue":"41","key":"10.1016\/j.amepre.2025.108085_bib0028","doi-asserted-by":"crossref","first-page":"E1399","DOI":"10.1503\/cmaj.230459","article-title":"Predictors of fatal and nonfatal overdose after prescription of opioids for chronic pain: a systematic review and meta-analysis of observational studies","volume":"195","author":"Wang","year":"2023","journal-title":"CMAJ"},{"issue":"2","key":"10.1016\/j.amepre.2025.108085_bib0029","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/ije\/dyr218","article-title":"Recommendations for presenting analyses of effect modification and interaction","volume":"41","author":"Knol","year":"2012","journal-title":"Int J Epidemiol"},{"issue":"10","key":"10.1016\/j.amepre.2025.108085_bib0030","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1093\/pm\/pny295","article-title":"Individuals with chronic pain who misuse prescription opioids report sex-based differences in pain and opioid withdrawal","volume":"20","author":"Huhn","year":"2019","journal-title":"Pain Med"},{"issue":"1","key":"10.1016\/j.amepre.2025.108085_bib0031","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1186\/s12891-022-05992-5","article-title":"General self-efficacy and social support in men and women with pain - irregular sex patterns of cross-sectional and longitudinal associations in a general population sample","volume":"23","author":"Samulowitz","year":"2022","journal-title":"BMC Musculoskelet Disord"},{"issue":"7","key":"10.1016\/j.amepre.2025.108085_bib0032","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-070509","article-title":"Sex and gender differences in healthcare utilisation trajectories: a cohort study among Quebec workers living with chronic pain","volume":"13","author":"Lacasse","year":"2023","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.amepre.2025.108085_bib0033","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/pme.12501","article-title":"Sex differences in chronic pain management practices for patients receiving opioids from the Veterans Health Administration","volume":"16","author":"Oliva","year":"2015","journal-title":"Pain Med"},{"key":"10.1016\/j.amepre.2025.108085_bib0034","unstructured":"World Health Organization, 4. Withdrawal management, Clinical Guidelines for Withdrawal Management and Treatment of Drug Dependence in Closed Settings, 2009, WHO; Geneva, Switzerland https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK310652\/, Accessed September 22, 2025."},{"issue":"2","key":"10.1016\/j.amepre.2025.108085_bib0035","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.0919","article-title":"Exposure-response association between concurrent opioid and benzodiazepine use and risk of opioid-related overdose in Medicare Part D beneficiaries","volume":"1","author":"Hernandez","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.amepre.2025.108085_bib0036","first-page":"1","article-title":"Physician Office Visits at Which Benzodiazepines Were Prescribed: Findings From 2014-2016 National Ambulatory Medical Care Survey","volume":"137","author":"Santo","year":"2020","journal-title":"Natl Health Stat Report."},{"issue":"1","key":"10.1016\/j.amepre.2025.108085_bib0037","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jsat.2019.05.001","article-title":"Opioid medication discontinuation and risk of adverse opioid-related health care events","volume":"103","author":"Mark","year":"2019","journal-title":"J Subst Abuse Treat"},{"issue":"3","key":"10.1016\/j.amepre.2025.108085_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.japh.2020.12.019","article-title":"Factors associated with opioid-tapering success: a mixed methods study","volume":"61","author":"Kuntz","year":"2021","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"5","key":"10.1016\/j.amepre.2025.108085_bib0039","article-title":"The association of chronic pain and opioid withdrawal in men and women with opioid use disorder","volume":"240","author":"Ware","year":"2022","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.amepre.2025.108085_bib0040","doi-asserted-by":"crossref","first-page":"586","DOI":"10.21037\/apm.2019.12.10","article-title":"Tapering opioids: a comprehensive qualitative review","volume":"9","author":"Davis","year":"2020","journal-title":"Ann Palliat Med"},{"issue":"6","key":"10.1016\/j.amepre.2025.108085_bib0041","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2217\/pmt-2018-0040","article-title":"Tapering opioid therapy: clinical strategies","volume":"8","author":"Pergolizzi","year":"2018","journal-title":"Pain Manag"},{"issue":"2","key":"10.1016\/j.amepre.2025.108085_bib0042","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.drugalcdep.2019.02.030","article-title":"Age differences in emergency department utilization and repeat visits among patients with opioid use disorder at an urban safety-net hospital: a focus on young adults","volume":"200","author":"Choi","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"10.1016\/j.amepre.2025.108085_bib0043","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s11606-010-1313-1","article-title":"Dependence on emergency care among young adults in the United States","volume":"25","author":"Fortuna","year":"2010","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.amepre.2025.108085_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103169","article-title":"An outbreak of novel psychoactive substance benzodiazepines in the unregulated drug supply: preliminary results from a community drug checking program using point-of-care and confirmatory methods","volume":"93","author":"Laing","year":"2021","journal-title":"Int J Drug Policy"},{"issue":"34","key":"10.1016\/j.amepre.2025.108085_bib0045","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.15585\/mmwr.mm7034a2","article-title":"Trends in nonfatal and fatal overdoses involving benzodiazepines - 38 states and the District of Columbia, 2019\u20132020","volume":"70","author":"Liu","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.amepre.2025.108085_bib0046","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/pm\/pnae121","article-title":"Association of opioid tapering with pain-related emergency department visits, hospitalizations, and primary care visits: a retrospective cohort study","volume":"26","author":"Magnan","year":"2025","journal-title":"Pain Med"},{"issue":"2","key":"10.1016\/j.amepre.2025.108085_bib0047","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.55101","article-title":"Association between opioid tapering and subsequent health care use, medication adherence, and chronic condition control","volume":"6","author":"Magnan","year":"2023","journal-title":"JAMA Netw Open"}],"container-title":["American Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379725005537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379725005537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T07:53:06Z","timestamp":1772869986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749379725005537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0749379725005537"],"URL":"https:\/\/doi.org\/10.1016\/j.amepre.2025.108085","relation":{},"ISSN":["0749-3797"],"issn-type":[{"value":"0749-3797","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risks for Adverse Events by Sex and Age After Prescription Opioid Dose Reduction","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amepre.2025.108085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108085"}}